Sildenafil Tablet
Product Images NDC 68071-2537

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2537 9)

This is a label from a pharmaceutical company with information regarding a medication called Sildenafil 20mg, available in tablet form, with a lot number of 00000, and ND number of 68071-2537-09. The medication should be stored at a controlled temperature of 68-77°F and kept out of reach of children. The instructions advise to contact a doctor for medical advice about potential side effects and to call the FDA for reporting side effects. Expired pills should not be consumed.*

FDA Label Image

Figure1 (Sildenafil Figure 1)

FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

FDA Label Image

Figure3 (Sildenafil Figure 3)

This appears to be a drug interaction table with information on various drugs and their potential interactions with Acenocoumarol. The table includes the names of the drugs, along with abbreviations for various measurements and parameters such as INR, AUC, Cmax, and fold change. Some drugs have recommendations for dose adjustment while others require no adjustment. However, it is unclear what the information in the table means without further context.*

FDA Label Image

Figure4 (Sildenafil Figure 4)

FDA Label Image

Figure5 (Sildenafil Figure 5)

This appears to be a table of medical data related to the medication Sildenafil. It shows different factors such as the walk distance of patients, their functional capacity, age, gender, and medical history in relation to the use of Sildenafil. It seems to be evaluating the effectiveness of this medication for treating idiopathic PAH (pulmonary arterial hypertension), PAHCTD (PAH associated with connective tissue disease), and PAH resulting from surgical repair. It is difficult to make sense of the data due to the poor quality of the and the incomplete nature of the table.*

FDA Label Image

Figure6 (Sildenafil Figure 6)

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

The text is not fully understandable as it contains gibberish characters and missing letters. Therefore, it is not possible to generate a useful description.*

FDA Label Image

Structure (Sildenafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.